MedTrace Logo

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

NCT04173104 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-02-09

No results posted yet for this study

Summary

This study is to collect data about how 18FPARPi can be used together with PET/positron emission tomography and MRI/magnetic resonance imaging scans to take pictures of brain cancer

Conditions

Interventions

DIAGNOSTIC_TEST

PET/MR with [18F]PARPi

One PET/MR study (with up to 3 scan times) with \[18F\]PARPi

DRUG

[18F]PARPi

Injection of \<100ug of \[18F\]PARPi prior to 1 PET/MR

Sponsors & Collaborators

Principal Investigators

  • Robert Young, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2026-02-05
Completion
2026-02-05
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04173104 on ClinicalTrials.gov